Effects of IV Administration of Ketamine on the Analgesia Nociception Index (ANI) Measured With the PhysioDoloris
Brief Summary
This study evaluates effects of the analgesic ketamine on ANI measurements (Anti Nociceptive Index)
Study Design
| Study type: | Observational |
|---|---|
| Status: | Completed |
| Study results: | Has Results |
| Age: | 18 Years and older (Adult, Older Adult) |
| Enrollment: | 20 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Aug 12, 2020 | |
|---|---|---|
| Primary Completion: | Dec 12, 2020 | |
| Completion Date: | Dec 12, 2020 | |
| Study First Posted: | Oct 30, 2012 | |
| Results First Posted: | Aug 05, 2019 | |
| Last Updated: | Aug 05, 2019 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Researchers at the University of Washington are doing this study to find out if a commonly used anesthetic affects patients Analgesia Nociception Index (level of pain relief) during abdominal hysterectomy under general anesthesia.
The investigators will administer routine anesthesia care including Ketamine, a commonly used anesthetic, during the patients surgery. During the patients surgery, the investigators will monitor the patients level of pain relief using the PhysioDoloris monitor, which monitors the routinely used EKG monitor. Though not yet FDA approved, the PhysioDoloris is completely non-invasive and collects data from the EKG monitor.
Eligibility Criteria
| Sex: | Female |
|---|---|
| Minimum Age: | 18 |
More Details
| NCT Number: | NCT01717521 |
|---|---|
| Other IDs: | 42398 |
| Study URL: | https://ClinicalTrials.gov/show/NCT01717521 |
Last updated: Mar 18, 2021